Meeting
2020 ASCO Virtual Scientific Program
Discovery of a core-panel of markers for a blood-assay for cancer detection utilizing cfDNA methylation changes.
Authors
Lasika Seneviratne
SCORA/LA Cancer Network, Los Angeles, CA
Lasika Seneviratne , Steven Evans , Juvairiya Pulicharam , Nadir Arber , Jacob Kuint
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Clinical Trial Registration Number
NCT04264767, NCT04264754
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1522)
DOI
10.1200/JCO.2020.38.15_suppl.1522
Abstract #
1522
Poster Bd #
14
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
An ultrasensitive approach for cancer screening and tissue of origin prediction based on targeted methylation sequencing of cell-free DNA.
First Author: Tiancheng Han
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Enhanced blood-based colorectal cancer screening with improved performance in detection of early stage disease.
First Author: Sven Duenwald
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of methylation and fragmentation signals in the detection of early-stage colorectal cancer.
First Author: Pol Canal-Noguer
Poster
2021 ASCO Annual Meeting
Accurate early-stage colorectal cancer detection through analysis of cell-free circulating tumor DNA (ctDNA) methylation patterns.
First Author: James M. Kinross